Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genix Pharmaceuticals (TSE:GENX)
TSXV:GENX
Genix Pharmaceuticals (GENX) Stock Price & Analysis
1 Followers
GENX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.10
Previous CloseC$0.08
Volume1.43K
Average Volume (3M)4.83K
Market Cap
C$4.74M
Enterprise ValueC$5.97M
Total Cash (Recent Filing)C$9.55K
Total Debt (Recent Filing)C$1.24M
Price to Earnings (P/E)―
Beta-0.20
Next Earnings
Sep 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding59,224,131
10 Day Avg. Volume3,300
30 Day Avg. Volume4,826
Standard Deviation0.31
R-Squared0.00549
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)-4.43
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-31.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genix Pharmaceuticals News
PremiumCompany Announcements
Genix Pharmaceuticals Enhances Warrant TermsOptions Prices
Currently, No data available
---
Ownership Overview
29.85% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
70.15% Public Companies and
Individual Investors
GENX FAQ
What was Genix Pharmaceuticals’s price range in the past 12 months?
Genix Pharmaceuticals lowest stock price was C$0.01 and its highest was C$0.10 in the past 12 months.
What is Genix Pharmaceuticals’s market cap?
Currently, no data Available
When is Genix Pharmaceuticals’s upcoming earnings report date?
Genix Pharmaceuticals’s upcoming earnings report date is Sep 26, 2024 which is in 62 days.
How were Genix Pharmaceuticals’s earnings last quarter?
Genix Pharmaceuticals released its earnings results on Jun 26, 2024. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Genix Pharmaceuticals overvalued?
According to Wall Street analysts Genix Pharmaceuticals’s price is currently Overvalued.
Does Genix Pharmaceuticals pay dividends?
Genix Pharmaceuticals does not currently pay dividends.
What is Genix Pharmaceuticals’s EPS estimate?
Genix Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genix Pharmaceuticals have?
Genix Pharmaceuticals has 59,224,133 shares outstanding.
What happened to Genix Pharmaceuticals’s price movement after its last earnings report?
Genix Pharmaceuticals reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genix Pharmaceuticals?
Currently, no hedge funds are holding shares in TSE:GENX
---
Genix Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.28%
12-Months-Change
Fundamentals
Return on Equity
-560.53%
Trailing 12-Months
Asset Growth
-93.85%
Trailing 12-Months
Company Description
Genix Pharmaceuticals
Genix Pharmaceuticals Corp is a Canadian life sciences company engaged in the research, development, manufacturing and marketing of high growth, high margin, novel and proprietary, evidence-based, pharmaceuticals, over-the-counter products, nutraceuticals and healthcare products, as well as generic medicines.
---
Technical Analysis
---